Literature DB >> 20055662

Porcine endothelial cells cocultured with smooth muscle cells became procoagulant in vitro.

Zhengyu Pang1, Laura E Niklason, George A Truskey.   

Abstract

Endothelial cell (EC) seeding represents a promising approach to provide a nonthrombogenic surface on vascular grafts. In this study, we used a porcine EC/smooth muscle cell (SMC) coculture model that was previously developed to examine the efficacy of EC seeding. Expression of tissue factor (TF), a primary initiator in the coagulation cascade, and TF activity were used as indicators of thrombogenicity. Using immunostaining, primary cultures of porcine EC showed a low level of TF expression, but a highly heterogeneous distribution pattern with 14% of ECs expressing TF. Quiescent primary cultures of porcine SMCs displayed a high level of TF expression and a uniform pattern of staining. When we used a two-stage amidolytic assay, TF activity of ECs cultured alone was very low, whereas that of SMCs was high. ECs cocultured with SMCs initially showed low TF activity, but TF activity of cocultures increased significantly 7-8 days after EC seeding. The increased TF activity was not due to the activation of nuclear factor kappa-B on ECs and SMCs, as immunostaining for p65 indicated that nuclear factor kappa-B was localized in the cytoplasm in an inactive form in both ECs and SMCs. Rather, increased TF activity appeared to be due to the elevated reactive oxygen species levels and contraction of the coculture, thereby compromising the integrity of EC monolayer and exposing TF on SMCs. The incubation of cocultures with N-acetyl-cysteine (2 mM), an antioxidant, inhibited contraction, suggesting involvement of reactive oxygen species in regulating the contraction. The results obtained from this study provide useful information for understanding thrombosis in tissue-engineered vascular grafts.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20055662      PMCID: PMC2949264          DOI: 10.1089/ten.TEA.2009.0448

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  48 in total

1.  Reactive oxygen species alter contractile properties of pulmonary arterial smooth muscle.

Authors:  R A Rhoades; C S Packer; D A Roepke; N Jin; R A Meiss
Journal:  Can J Physiol Pharmacol       Date:  1990-12       Impact factor: 2.273

2.  Expression of tissue factor procoagulant activity: regulation by cytosolic calcium.

Authors:  R Bach; D B Rifkin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  Expression of tissue factor pathway inhibitor by cultured endothelial cells in response to inflammatory mediators.

Authors:  A Ameri; M N Kuppuswamy; S Basu; S P Bajaj
Journal:  Blood       Date:  1992-06-15       Impact factor: 22.113

4.  Correlation between antigenic and functional expression of tissue factor on the surface of cultured human endothelial cells following stimulation by lipopolysaccharide endotoxin.

Authors:  M Noguchi; T Sakai; W Kisiel
Journal:  Thromb Res       Date:  1989-07-01       Impact factor: 3.944

5.  Serum stimulation of quiescent human fibroblasts induces the synthesis of tissue factor mRNA followed by the appearance of tissue factor antigen and procoagulant activity.

Authors:  L J Bloem; L Chen; W H Konigsberg; R Bach
Journal:  J Cell Physiol       Date:  1989-05       Impact factor: 6.384

6.  Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.

Authors:  T A Drake; J H Morrissey; T S Edgington
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

7.  The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester.

Authors:  D C Crossman; D P Carr; E G Tuddenham; J D Pearson; J H McVey
Journal:  J Biol Chem       Date:  1990-06-15       Impact factor: 5.157

8.  Cultured human endothelial cells generate tissue factor in response to endotoxin.

Authors:  M Colucci; G Balconi; R Lorenzet; A Pietra; D Locati; M B Donati; N Semeraro
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

9.  Endothelium properties of a tissue-engineered blood vessel for small-diameter vascular reconstruction.

Authors:  Murielle Rémy-Zolghadri; Josée Laganière; Jean-François Oligny; Lucie Germain; François A Auger
Journal:  J Vasc Surg       Date:  2004-03       Impact factor: 4.268

10.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1.

Authors:  R Schreck; P Rieber; P A Baeuerle
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

View more
  5 in total

1.  Endothelial Cell Vascular Smooth Muscle Cell Co-Culture Assay For High Throughput Screening Assays For Discovery of Anti-Angiogenesis Agents and Other Therapeutic Molecules.

Authors:  George A Truskey
Journal:  Int J High Throughput Screen       Date:  2010-10-01

2.  In vitro 3D angiogenesis assay in egg white matrix: comparison to Matrigel, compatibility to various species, and suitability for drug testing.

Authors:  Yoanne Mousseau; Séverine Mollard; Hao Qiu; Laurence Richard; Raphael Cazal; Angélique Nizou; Nicolas Vedrenne; Séverine Rémi; Yasser Baaj; Laurent Fourcade; Benoit Funalot; Franck G Sturtz
Journal:  Lab Invest       Date:  2014-01-06       Impact factor: 5.662

3.  Orthogonal co-cultivation of smooth muscle cell and endothelial cell layers to construct in vivo-like vasculature.

Authors:  Jong Seob Choi; Tae Seok Seo
Journal:  Biomicrofluidics       Date:  2019-02-26       Impact factor: 2.800

4.  Hydraulic conductivity of endothelial cell-initiated arterial cocultures.

Authors:  Rishi A Mathura; Sparkle Russell-Puleri; Limary M Cancel; John M Tarbell
Journal:  Ann Biomed Eng       Date:  2013-11-22       Impact factor: 3.934

5.  Hydraulic Conductivity of Smooth Muscle Cell-Initiated Arterial Cocultures.

Authors:  Rishi A Mathura; Sparkle Russell-Puleri; Limary M Cancel; John M Tarbell
Journal:  Ann Biomed Eng       Date:  2015-08-12       Impact factor: 3.934

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.